Treg cell-based therapies: challenges and perspectives

• Fibroblasts—The emerging therapeutic target of the cardiovascular system?

  2025 Pharmacological Reviews article Medicine Cardiac Fibrosis and Remodeling Open access

  4

  citations
• Immune suppression by human thymus-derived effector Tregs relies on glucose/lactate-fueled fatty acid synthesis

  2024 Cell Reports article Immunology and Microbiology T-cell and B-cell Immunology Open access

  17

  citations
• Targeting immune cell recruitment in atherosclerosis

  2024 Nature Reviews Cardiology review Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases

  84

  citations
• Tregs from human blood differentiate into nonlymphoid tissue–resident effector cells upon TNFR2 costimulation

  2024 JCI Insight article Immunology and Microbiology T-cell and B-cell Immunology Open access

  15

  citations
• An Integrated Glycosylation Signature of Rheumatoid Arthritis

  2023 Biomolecules article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access

  19

  citations
• The autoimmune response as a potential target for tolerance induction before the development of rheumatoid arthritis

  2021 The Lancet Rheumatology article Medicine Rheumatoid Arthritis Research and Therapies

  6

  citations
• Editorial: Strategies for Modulating T Cell Responses in Autoimmunity and Infection

  2020 Frontiers in Immunology editorial Immunology and Microbiology T-cell and B-cell Immunology Open access

  3

  citations

7 results